Published 13 May 2020
Introduction
In recent weeks, at least seven class action lawsuits have
been filed in federal district courts throughout the United
States against the government of the People's Republic of China
(the "P.R.C." or "China"), all relating to China's alleged
liability for damages and injuries sustained in the ongoing
COVID-19 pandemic. Although plaintiffs in these lawsuits make
broadly different claims, they all face the same highly
formidable legal roadblock: a need to find exceptions that can
pierce the presumptive immunity afforded to China and other
sovereign nations under the Foreign Sovereign Immunities Act
("FSIA"), 28 U.S.C. § 1602, et seq., which would
otherwise preclude their claims at the outset for lack of
jurisdiction.
To read this article you need to be a subscriber
Subscribe
Fill in the registration form and answer a few simple questions to receive a quote.
Subscribe now
Suggested Citation
M. Diaz, Jr.; M. Colomar-Garcia; B.C. Hadaway; G.E. Davidson; X.J. Zhao; J. Coronado; Z. Pan (2020, forthcoming) "The Façade of COVID-19 Class Action Litigation Against China Under the Foreign Sovereign Immunities Act"
(TDM, ISSN 1875-4120) May 2020, www.transnational-dispute-management.com
Other recently published material:
The Overlap Between Insolvency Proceedings and Arbitration: The Potential for Abuse and Inconsistent Results?
30 March 2021
Exploring the Intersection of Insolvency and Arbitration Proceedings in Australia, Malaysia, and Singapore
26 March 2021
Court of Arbitration for Sport: A Forgotten Model for ISDS?
24 March 2021
Liquidated Damages for Late/Non-Compliance with an Arbitration Award - Dealing with the Prohibition of Riba under Shari'ah in Awarding Post-Award Interest in International Arbitration
19 March 2021
Now available in TDM 6 (2020): When Capital Meets Custom. (How) Can State-Controlled Enterprises Contribute to the Formation/Identification of Customary International (Investment) Law?
18 March 2021
Complete listing of Advance publication.